發(fā)布時(shí)間：2018-02-15 01:58

  本文關(guān)鍵詞： 張燦 腦膠質(zhì)瘤 Nature 中國(guó)藥科大學(xué) 高復(fù)發(fā)率 recurrence suppression glioma anticancer 侵襲性生長(zhǎng) 　出處：《中國(guó)藥科大學(xué)學(xué)報(bào)》2017年04期 　論文類型：期刊論文

【摘要】：正中國(guó)藥科大學(xué)張燦教授課題組的論文"Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence"于2017年6月19日在線發(fā)表于Nature子刊"Nature Nanotechnology"(doi:10.1038/nnano.2017.54,IF 38.986)。該論文立足于腦膠質(zhì)瘤的術(shù)后化療。腦膠質(zhì)瘤是顱內(nèi)最常見的惡性侵襲性生長(zhǎng)腫瘤,具有高死亡率、高復(fù)發(fā)率
[Abstract]:"Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence," published online June 19th 2017 in Nature Nanotechnology, "Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence," published in the Nature subjournal Nature Nanotechnology. Common malignant invasive growth tumors, Have a high mortality rate, a high recurrence rate
【分類號(hào)】：R739.41
，

本文編號(hào)：1512153